AlzeCure Pharma (Sweden) Top Management
ALZCUR Stock | SEK 1.19 0.16 15.53% |
AlzeCure Pharma employs about 14 people. The company is managed by 5 executives with a total tenure of roughly 13 years, averaging almost 2.0 years of service per executive, having 2.8 employees per reported executive. Analysis of AlzeCure Pharma's management performance can provide insight into the company performance.
Marta MD Insider Chief Officer |
Martin Jnsson Insider Chief Officer |
AlzeCure |
AlzeCure Pharma Management Team Effectiveness
The company has return on total asset (ROA) of (0.7846) % which means that it has lost $0.7846 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (1.5536) %, meaning that it generated substantial loss on money invested by shareholders. AlzeCure Pharma's management efficiency ratios could be used to measure how well AlzeCure Pharma manages its routine affairs as well as how well it operates its assets and liabilities.AlzeCure Pharma Workforce Comparison
AlzeCure Pharma is number one stock in number of employees category among its peers. The total workforce of Drug Manufacturers - Specialty & Generic industry is presently estimated at about 1,391. AlzeCure Pharma claims roughly 14.0 in number of employees contributing just under 2% to equities under Drug Manufacturers - Specialty & Generic industry.
AlzeCure Pharma Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. AlzeCure Pharma Price Series Summation is a cross summation of AlzeCure Pharma price series and its benchmark/peer.
AlzeCure Pharma Notable Stakeholders
An AlzeCure Pharma stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as AlzeCure Pharma often face trade-offs trying to please all of them. AlzeCure Pharma's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting AlzeCure Pharma's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Pontus Forsell | Director Pharmacology | Profile | |
Marta MD | Chief Officer | Profile | |
Martin Jnsson | Chief Officer | Profile | |
Johan Sandin | Chief Officer | Profile | |
Birgitta Lundvik | Chief Officer | Profile |
About AlzeCure Pharma Management Performance
The success or failure of an entity such as AlzeCure Pharma often depends on how effective the management is. AlzeCure Pharma management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of AlzeCure management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the AlzeCure management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
AlzeCure Pharma AB develops therapies for the treatment of Alzheimer s disease and related neurodegenerative disorders. The company was founded in 2012 and is based in Huddinge, Sweden. AlzeCure Pharma is traded on Stockholm Stock Exchange in Sweden.
Please note, the presentation of AlzeCure Pharma's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, AlzeCure Pharma's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of AlzeCure Pharma's management manipulating its earnings.
AlzeCure Pharma Workforce Analysis
Traditionally, organizations such as AlzeCure Pharma use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare AlzeCure Pharma within its industry.AlzeCure Pharma Manpower Efficiency
Return on AlzeCure Pharma Manpower
Revenue Per Employee | 0.0 | |
Revenue Per Executive | 0.0 | |
Net Loss Per Employee | 5.6M | |
Net Loss Per Executive | 15.6M |
Complementary Tools for AlzeCure Stock analysis
When running AlzeCure Pharma's price analysis, check to measure AlzeCure Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AlzeCure Pharma is operating at the current time. Most of AlzeCure Pharma's value examination focuses on studying past and present price action to predict the probability of AlzeCure Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move AlzeCure Pharma's price. Additionally, you may evaluate how the addition of AlzeCure Pharma to your portfolios can decrease your overall portfolio volatility.
Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Stocks Directory Find actively traded stocks across global markets | |
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine |